Mulmit

CVRx, Inc.CVRx, Inc.

CVRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3156,651,000-51,265,000-53,306,000-2.04
2024-12-3151,292,000-59,490,000-59,965,000-2.65
2023-12-3139,295,000-43,103,000-41,199,000-1.99
2022-12-3122,469,000-42,527,000-41,428,000-2.02
2021-12-3113,036,000-25,968,000-43,078,000-4.16

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-13Binkowski BrentCHIEF OPERATING OFFICER26,223
2026-08-12Binkowski BrentCHIEF OPERATING OFFICER1,309
2026-06-01SHADAN MARTHA8,720
2026-06-01SHADAN MARTHA11,182
2026-06-01Hill, Mitch C.8,720
2026-06-01Hill, Mitch C.11,182
2026-06-01Jain Mudit K.8,720
2026-06-01Jain Mudit K.11,182
2026-06-01Ballinger Kevin J.8,720
2026-06-01Ballinger Kevin J.11,182
2026-06-01Nielsen Kirk G.8,720
2026-06-01Nielsen Kirk G.11,182

8-K events

FiledItems
2026-08-11Officer or director change · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-06-09Officer or director change · Financial statements and exhibits
2026-06-03Submission of matters to a vote
2026-05-11Results of operations · Financial statements and exhibits
2026-04-13Results of operations · Other events · Financial statements and exhibits
2026-03-03Officer or director change · Financial statements and exhibits
2026-02-12Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Surgical & Medical Instruments & Apparatus — 같은 업종, 그리고 규모가 비슷한 기업Surgical & Medical Instruments & Apparatus — and other companies of a similar size

SEC가 같은 업종(Surgical & Medical Instruments & Apparatus)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Surgical & Medical Instruments & Apparatus) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.